For identification of microglia and macrophages, the F4/80 marker was used (Dianova, Hamburg, Germany). It is a commonly used marker for hematopoietic cells in the developing or adult mouse CNS, including the neural retina
23–25 and nonneuronal tissues, such as the CB or choroid, that are part of the uveal tract.
11,16,26 We defined microglia as ramified cells (highly branched or somewhat truncated, with thick processes) in the neural retina adjacent to blood vessels, and macrophages as ameboid or large globular cells in the nonneural tissue (nerve fiber layer [NFL], choroids, and CB), in accordance with previous studies.
6,16 Microglia and macrophage identity was further confirmed by using a marker against the ionized calcium-binding adaptor molecule (Iba)-1.
An established method of labeling dividing cells is based on the use and administration of the exogenous marker 5′-bromo-2-deoxyuridine (BrdU; Sigma-Aldrich), which is incorporated in the S-phase of the cell cycle (DNA synthesis).
27 This method allows for tracking the fate of proliferating cells, and their progeny and is widely used,
28–30 in particular for identification of cells with a low proliferation rate.
29,31,32
Since apoptotic cells also re-enter the cell cycle,
33,34 terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL; Roche Applied Science, Mannheim, Germany) was performed to exclude apoptotic nuclear cell labeling and, moreover, to estimate the number and time course of apoptotic RGCs in acute phase after both lesion types.
The in situ proliferation of retinal and ciliary F4/80
+ immunologic cells was analyzed over time by using the Ki67 marker (Novacastra, Newcastle-upon-Tyne, UK). The Ki67 antigen is an endogenous nuclear protein that is expressed in all active phases of the cell cycle, including the late G
1, S, G
2, and mitosis phases, and is often used as a marker of mitosis.
27,29
For staining, retinal slices were dried, fixed with 4% PFA for 10 minutes, and washed twice in PBS at room temperature (RT). For BrdU and Ki67 co-staining, the tissue was pretreated with EDTA buffer [pH 8.0] for heat-induced epitope retrieval. For BrdU and F4/80 costaining, tissue was pretreated with 2 N HCl for 20 minutes at 37°C, followed by 0.1 M borate buffer (pH 8.5) usage for 10 minutes, and subsequent washing. Afterward, the slices were permeabilized and blocked with 1% bovine serum albumin (BSA) in PBS, supplemented with 0.3% TritonX-100 and 10% normal donkey serum (NDS) for 2 hours at RT. After nonspecific binding was blocked, the tissue was incubated with primary antisera in 2% NDS, overnight at 4°C. The following antibodies were used: mouse anti-BrdU (1:500; Serotec, Heidelberg, Germany), rat anti-BrdU (1:500; Serotec), rabbit anti-Ki67 (1:100; Novacastra), mouse anti-PCNA (1:100; Signet Laboratories, Dedham, MA), rat anti-F4/80 (1:100; Dianova), rabbit anti-Iba1 (1:500; Wako, Neuss, Germany), rat anti-CD68 (1:100; Serotec), rabbit anti–von Willebrand factor (1:250; Dako, Hamburg, Germany), and mouse anti-NeuN (1:500; Millipore, Eschborn, Germany). After the sections were washed with PBS, they were incubated with secondary antibodies in 10% NDS for 1 hour at RT. Secondary antibodies were donkey anti-rat IgG rhodamine (RhodamineX Red, 1:1000; Dianova); donkey anti-mouse IgG Alexa Fluor 488, donkey anti-rabbit IgG Alexa Fluor 488, and goat anti-rat IgG Alexa Fluor 488 (1:500; Molecular Probes, Leiden, The Netherlands); and goat anti-mouse IgG Cy3, donkey anti-mouse Cy5, and donkey anti-rabbit F(ab)′2 Cy5 (1:500; Dianova). As a test for specificity, some sections were incubated without primary antibodies. The nuclei were counterstained with DAPI (4,6-diamino-2-phenylindole; Sigma) for 5 minutes at RT. TUNEL labeling was performed with a cell-detection kit (Fluorescein In Situ Cell Detection Kit; Roche Applied Science) according to the manufacturer's instructions. For a positive control, some sections were treated with DNase I (1 μg/mL; Sigma) before the TUNEL reaction.